Article
Induction of anti-melanoma CTL response using DC transfected with mutated mRNA encoding full-length Melan-A/MART-1 antigen with an A27L amino acid substitution.
Cellular immunology - 1 Aug 2003
Abdel-Wahab Zeinab, Kalady Matthew F, Emani Sirisha, Onaitis Mark W, Abdel-Wahab Omar I, Cisco Robin, Wheless Lee, Cheng Tsung-Yen, Tyler Douglas S, Pruitt Scott K
Abstract excerpt
Modification of the parental immunodominant Melan-A/MART-1 peptide (MART-1(26-35)) by replacing the alanine with leucine (A27L) enhances its immunogenicity. Because of the reported advantages of RNA over peptides in DC vaccines, we sought to mutate the MART-1 gene to encode a full-length MART-1 antigen with an A27L amino acid substitution. Human DC were transfected with A27L-mutated MART-1 RNA (A27L RNA) or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
